Therapeutic modulation of cytokines. (Q40458523)

20 September 2017

1 reference

title

Therapeutic modulation of cytokines. (English)

1 reference

20 September 2017

Henderson B

1

1 reference

PMCID

1009916

20 September 2017

language of work or name

English

0 references

publication date

1 June 1995

1 reference

Annals of the Rheumatic Diseases

20 September 2017

1 reference

20 September 2017

54

1 reference

20 September 2017

6

1 reference

20 September 2017

519-523

1 reference

Structure and mechanism of interleukin-1 beta converting enzyme

20 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1009916

FK506 and ciclosporin: molecular probes for studying intracellular signal transduction

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1009916

Interleukin 1 induces leukocyte infiltration and cartilage proteoglycan degradation in the synovial joint

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1009916

How important are T cells in chronic rheumatoid synovitis?

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1009916

Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1009916

Interleukin 1 beta and thioredoxin are secreted through a novel pathway of secretion

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1009916

Therapeutic potential of cytokine manipulation

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1009916

Involvement of endogenous tumor necrosis factor alpha and transforming growth factor beta during induction of collagen type II arthritis in mice

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1009916

Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1009916

Experimental arthritis models in the study of the mechanisms of articular cartilage loss in rheumatoid arthritis.

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1009916

Modulation of cytokine function: therapeutic applications.

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1009916

Regulation of tumour necrosis factor-alpha processing by a metalloproteinase inhibitor

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1009916

Protection against a lethal dose of endotoxin by an inhibitor of tumour necrosis factor processing

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1009916

Prevention of lipopolysaccharide-induced lethal toxicity by tyrosine kinase inhibitors

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1009916

A specific inhibitor of the epidermal growth factor receptor tyrosine kinase

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1009916

Designing CD4 immunoadhesins for AIDS therapy

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1009916

C3 activation products correlate with antibodies to lipid A in pauciarticular juvenile arthritis

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1009916

Design and synthesis of a mimetic from an antibody complementarity-determining region.

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1009916

Processing of tumour necrosis factor-α precursor by metalloproteinases

15 June 2018

1 reference

12 December 2020

Suppression and augmentation of rat adjuvant arthritis with monoclonal anti-interferon-gamma antibody

1 reference

12 December 2020

Protection against cartilage proteoglycan synthesis inhibition by antiinterleukin 1 antibodies in experimental arthritis

1 reference

12 December 2020

IX 207-887 in rheumatoid arthritis. A double-blind placebo-controlled study

1 reference

12 December 2020

Interleukin 1 receptor antagonist (IL-1ra) prevents or cures pulmonary fibrosis elicited in mice by bleomycin or silica

1 reference

12 December 2020

Reduction of acute-phase proteins with tenidap sodium, a cytokine-modulating anti-rheumatic drug

1 reference

12 December 2020

Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor α

1 reference

12 December 2020

The effect of recombinant human interleukin 1 receptor antagonist on the induction phase of antigen induced arthritis in the rabbit

1 reference

12 December 2020

Identifiers

DOI

10.1136/ARD.54.6.519

1 reference

20 September 2017

1 reference

20 September 2017

1 reference

PMCID

1009916